BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 35562515)

  • 1. Discoidin domain receptor 1 promotes lung adenocarcinoma migration via the AKT/snail signaling axis.
    Zhu J; Cheng H; Wang L; Xu W; Wang J; Han Q; Lee JH; Du L; Lyu J
    Mol Biol Rep; 2022 Aug; 49(8):7275-7286. PubMed ID: 35562515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma.
    Nokin MJ; Darbo E; Travert C; Drogat B; Lacouture A; San José S; Cabrera N; Turcq B; Prouzet-Mauleon V; Falcone M; Villanueva A; Wang H; Herfs M; Mosteiro M; Jänne PA; Pujol JL; Maraver A; Barbacid M; Nadal E; Santamaría D; Ambrogio C
    JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32759499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
    Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
    Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
    [No Abstract]   [Full Text] [Related]  

  • 5. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD73 (NT5E) Promotes the Proliferation and Metastasis of Lung Adenocarcinoma through the EGFR/AKT/mTOR Pathway.
    Zhang H; Cao Y; Tang J; Wang R
    Biomed Res Int; 2022; 2022():9944847. PubMed ID: 35813221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA (let-7b-5p)-targeted DARS2 regulates lung adenocarcinoma growth by PI3K/AKT signaling pathway.
    Xu Y; Chen X
    Oncol Res; 2024; 32(3):517-528. PubMed ID: 38361754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLC39A5 promotes lung adenocarcinoma cell proliferation by activating PI3K/AKT signaling.
    Liu Z; Hu Z; Cai X; Liu S
    Pathol Res Pract; 2021 Aug; 224():153541. PubMed ID: 34252710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long noncoding RNA LINC00483 promotes lung adenocarcinoma progression by sponging miR-204-3p.
    Yang S; Liu T; Sun Y; Liang X
    Cell Mol Biol Lett; 2019; 24():70. PubMed ID: 31889958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K/AKT signaling pathway.
    Li M; Liu Z; Hou Z; Wang X; Shi H; Li Y; Xiao X; Tang Z; Yang J; Luo Y; Zhang M; Chen M
    Thorac Cancer; 2023 May; 14(14):1223-1238. PubMed ID: 36944484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway.
    Zhu HE; Yin JY; Chen DX; He S; Chen H
    Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-canonical role of endothelin converting enzyme 1 (ECE1) in promoting lung cancer development via directly targeting protein kinase B (AKT).
    Chen L; Lu Y; Zhao M; Xu J; Wang Y; Xu Q; Cao Y; Liu H
    J Gene Med; 2024 Jan; 26(1):e3612. PubMed ID: 37897251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TMEM158 functions as an oncogene and promotes lung adenocarcinoma progression through the PI3K/AKT pathway via interaction with TWIST1.
    Xu T; Yin F; Shi K
    Exp Cell Res; 2024 Apr; 437(1):114010. PubMed ID: 38508329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis.
    Sun D; Zhu Y; Zhao H; Bian T; Li T; Liu K; Feng L; Li H; Hou H
    Cell Oncol (Dordr); 2021 Oct; 44(5):1019-1034. PubMed ID: 34109546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of FYN suppresses the epithelial-to-mesenchymal transition through down-regulating PI3K/AKT pathway in lung adenocarcinoma.
    Xue F; Jia Y; Zhao J
    Surg Oncol; 2020 Jun; 33():108-117. PubMed ID: 32561075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of DDR1 Promotes Migration, Invasion, Though EMT-Related Molecule Expression and COL4A1/DDR1/MMP-2 Signaling Axis.
    Xie X; He H; Zhang N; Wang X; Rui W; Xu D; Zhu Y
    Technol Cancer Res Treat; 2020; 19():1533033820973277. PubMed ID: 33234027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal peptidase 21 suppresses cell proliferation, migration, and invasion via the PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma.
    Zhang N; Cao S; Sun R; Wang Y; Liu L; Wang W; Meng X
    PeerJ; 2022; 10():e14206. PubMed ID: 36275477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing LINC01116 suppresses the development of lung adenocarcinoma via the AKT signaling pathway.
    Shang B; Li Z; Li M; Jiang S; Feng Z; Cao Z; Wang H
    Thorac Cancer; 2021 Jul; 12(14):2093-2103. PubMed ID: 34061456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
    Lu GS; Li M; Xu CX; Wang D
    Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma.
    Wang Y; Mei X; Song W; Wang C; Qiu X
    BMC Pulm Med; 2022 Jul; 22(1):272. PubMed ID: 35842617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.